Longevity Hype Check
Anti-aging, senolytics, lifespan trials — what is evidence and what is marketing? HYPEXIO scores longevity stories on reality and hype, instead of reprinting promises.
We track clinical trials, healthspan research, and anti-aging claims. This page separates verified findings from over-hyped press releases — based on the latest longevity briefings in the feed.
What holds up
5Phase III data, peer-reviewed results, multiple trial arms. High reality scores, low hype.
-
Longevity Clinics Converge on a Core Biomarker Dashboard
Preventive medicine has quietly standardized around a short list of tests that most GPs still don't order. If you're 45 and haven't checked your ApoB or VO₂Max, you're flying blind on the metrics that actually predict healthspan.
Reality 72Hype 55 -
ARDD 2025 Report Maps Nearest-Term Human Aging Interventions
The longevity field's most cited annual gathering just published its 2025 consensus report — and the emphasis has shifted hard from mechanisms to actionable clinical interventions. The message: the biology is mature enough to act on.
Reality 72Hype 58 -
Longevity Supplement Claims Outrun the Human Trial Evidence
The longevity supplement market is selling "ageless vitality" on the back of largely preclinical or animal data. Industry insiders are now publicly admitting the evidence gap — and calling for human trials to close it.
Reality 72Hype 25 -
Cellular Rejuvenation Therapy Targets Aging as a Treatable Condition
Aging may soon be classified not as an inevitability but as a reversible biological state. Cellular rejuvenation therapies are moving from lab curiosity to credible clinical pipeline — with implications for hundreds of age-related diseases at once.
Reality 72Hype 55 -
Centenarian Blood Markers Reveal Biological Resilience Mechanisms
Scientists analyzing the blood of 100-year-olds have identified specific biological markers that appear to distinguish people who survive to extreme age — not by avoiding disease, but by recovering from it faster and more completely than the rest of us.
Reality 65Hype 45